Interrelationships among asthma, atopy, rhinitis and exhaled nitric oxide in a population-based sample of children

Clinical and Experimental Allergy

Volumn 33, Issue 11, 2003, Pages 1506-1511

  Jouaville, L F ^a   Annesi Maesano, I ^b   Nguyen, L T ^a   Bocage, A S ^a   Bedu, M ^a   Caillaud, D ^a,c  

^a Physiology and Pulmonary Department   (France)

^b INSERM   (France)

^c SERVICE DE RHUMATOLOGIE   (France)

Author keywords

Asthma; Atopy; Children; Exhaled nitric oxide; Rhinitis; Skin prick test

Indexed keywords

ALLERGEN; NITRIC OXIDE;

ALLERGIC ASTHMA; ALLERGIC RHINITIS; ARTICLE; ASTHMA; ATOPY; BREATH ANALYSIS; CHILDHOOD; CONTROLLED STUDY; CORRELATION ANALYSIS; EXHALATION; FEMALE; HEALTH SURVEY; HUMAN; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PRICK TEST; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RHINITIS; SCHOOL CHILD; SKIN TEST;

ANALYSIS OF VARIANCE; ANTHROPOMETRY; ASTHMA; BREATH TESTS; CHILD; FEMALE; HUMANS; HYPERSENSITIVITY, IMMEDIATE; MALE; NITRIC OXIDE; RHINITIS; SKIN TESTS;

EID: 0242721850     PISSN: 09547894     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2222.2003.01800.x     Document Type: Article

References (51)

1. Koarai A, Ichinose M, Sugiura H, Yamagata S, Hattori T, Shirato K. Allergic airway hyperresponsiveness and eosinophil infiltration is reduced by a selective iNOS inhibitor, 1400W, in mice. Pulm Pharmacol Ther 2000; 13:267-75.
2. Alving K, Weitzberg E, Lundberg JM. Increased amount of nitric oxide in exhaled air of asthmatics. Eur Respir J 1993; 6:1368-70.
3. Kharitonov SA, Yates D, Robbins RA, Logan-Sinclair R, Shinebourne EA, Barnes PJ. Increased nitric oxide in exhaled air of asthmatic patients. Lancet 1994; 343:133-5.
4. Kharitonov SA, Yates DH, Barnes PJ. Inhaled glucocorticoids decrease nitric oxide in exhaled air of asthmatic patients. Am J Respir Crit Care Med 1996; 153:454-7.
5. Kharitonov SA, Yates DH, Chung KF, Barnes PJ. Changes in the dose of inhaled steroid affect exhaled nitric oxide levels in asthmatic patients. Eur Respir J 1996; 9:196-201.
6. Kharitonov SA, Barnes PJ. Nitric oxide in exhaled air is a new marker of airway inflammation. Monaldi Arch Chest Dis 1996; 51:533-7.
7. Frank TL, Adisesh A, Pickering AC et al. Relationship between exhaled nitric oxide and childhood asthma. Am J Respir Crit Care Med 1998; 158:1032-6.
8. Henriksen AH, Sue-Chu M, Lingaas Holmen T, Langhammer A, Bjermer L. Exhaled and nasal NO levels in allergic rhinitis: relation to sensitization, pollen season and bronchial hyperresponsiveness. Eur Respir J 1999; 13:301-6.
9. The International Study of Asthma and Allergies in Childhood (ISAAC) Steering Committee. Worldwide variation in prevalence of symptoms of asthma, allergic rhinoconjunctivitis and atopic eczema: ISAAC. Lancet 1998; 351:1225-32.
10. Annesi-Maesano I, Didier A, Klossek M, Chanal I, Moreau D, Bousquet J. The score for allergc rhinitis (SFAR) - a simple and valid assessment in population. Allergy 2002; 57:107-14.
11. Kharitonov S, Alving K, Barnes PJ. Exhaled and nasal nitric oxide measurements: recommendations. The European Respiratory Society Task Force. Eur Respir J 1997; 10:1683-93.
12. Silkoff PE, Stevens A, Pak J, Bucher-Bartelson B, Martin RJ. A method for the standardized offline collection of exhaled nitric oxide. Chest 1999; 116:754-9.
13. Kissoon N, Duckworth LJ, Blake KV, Murphy SP, Taylor CL, Silkoff PE. FE(NO): relationship to exhalation rates and online versus bag collection in healthy adolescents. Am J Respir Crit Care Med 2000; 162:539-45.
14. Byrnes CA, Dinarevic S, Busst CA, Shinebourne EA, Bush A. Effect of measurement conditions on measured levels of peak exhaled nitric oxide. Thorax 1997; 52:697-701.
15. Henriksen AH, Lingaas-Holmen T, Sue-Chu M, Bjermer L. Combined use of exhaled nitric oxide and airway hyperresponsiveness in characterizing asthma in a large population survey. Eur Respir J 2000; 15:849-55.
16. Gratziou C, Lignos M, Dassiou M, Roussos C. Influence of atopy on exhaled nitric oxide in patients with stable asthma and rhinitis. Eur Respir J 1999; 14:897-901.
17. Silkoff PE, McClean PA, Slutsky AS et al. Marked flow-dependence of exhaled nitric oxide using a new technique to exclude nasal nitric oxide. Am J Respir Crit Care Med 1997; 155:260-7.
18. Franklin PJ, Taplin R, Stick SM. A community study of exhaled nitric oxide in healthy children. Am J Respir Crit Care Med 1999; 159:69-73.
19. Horvath I, Barnes PJ. Exhaled monoxides in asymptomatic atopic subjects. Clin Exp Allergy 1999; 29:1276-80.
20. Ho LP, Wood FT, Robson A, Innes JA, Greening AP. Atopy influences exhaled nitric oxide levels in adult asthmatics. Chest 2000; 118:1327-31.
21. Barreto M, Villa MP, Martella S et al. Exhaled nitric oxide in asthmatic and non-asthmatic children: influence of type of allergen sensitization and exposure to tobacco smoke. Pediatr Allergy Immunol 2001; 12:247-56.
22. Ying S, Humbert M, Meng Q et al. Local expression of epsilon germline gene transcripts and RNA for the epsilon heavy chain of IgE in the bronchial mucosa in atopic and nonatopic asthma. J Allergy Clin Immunol 2001; 107:686-92.
23. Ying S, Meng Q, Zeibecoglou K et al. Eosinophil chemotactic chemokines (eotaxin, eotaxin-2, RANTES, monocyte chemoattractant protein-3 (MCP-3), and MCP-4), and C-C chemokine receptor 3 expression in bronchial biopsies from atopic and nonatopic (intrinsic) asthmatics. J Immunol 1999; 163:6321-9.
24. Foresi A, Leone C, Pelucchi A et al. Eosinophils, mast cells, and basophils in induced sputum from patients with seasonal allergic rhinitis and perennial asthma: relationship to methacholine responsiveness. J Allergy Clin Immunol 1997; 100:58-64.
25. Braunstahl GJ, Kleinjan A, Overbeek SE, Prins JB, Hoogsteden HC, Fokkens WJ. Segmental bronchial provocation induces nasal inflammation in allergic rhinitis patients. Am J Respir Crit Care Med 2000; 161:2051-7.
26. Vignola AM, Bousquet J. Rhinitis and asthma: a continuum of disease? Clin Exp Allergy 2001; 31:674-7.
27. Rapp J, Kosa L, Halasz A, Kereki E, Borzsonyi L. Levels of interleukin-4, interleukin-5, tryptase and eosinophil cationic protein of nasal lavage fluid in pollen allergic rhinitis. Orv Hetil 2000; 141:1919-22.
28. Godthelp T, Holm AF, Fokkens WJ et al. Dynamics of nasal eosinophils in response to a nonnatural allergen challenge in patients with allergic rhinitis and control subjects: a biopsy and brush study. J Allergy Clin Immunol 1996; 97:800-11.
29. Karlsson MG, Hellquist HB. Phenotype switch and activation of T lymphocytes in patients with allergic rhinitis. ORL J Otorhinolaryngol Relat Spec 1994; 56:166-72.
30. Sihra BS, Kon OM, Grant JA, Kay AB. Expression of high-affinity IgE receptors (Fc epsilon RI) on peripheral blood basophils, monocytes, and eosinophils in atopic and nonatopic subjects: relationship to total serum IgE concentrations. J Allergy Clin Immunol 1997; 99:699-706.
31. Djukanovic R, Lai CK, Wilson JW et al. Bronchial mucosal manifestations of atopy: a comparison of markers of inflammation between atopic asthmatics, atopic nonasthmatics and healthy controls. Eur Respir J 1992; 5:538-44.
32. Chakir J, Laviolette M, Turcotte H, Boutet M, Boulet LP. Cytokine expression in the lower airways of nonasthmatic subjects with allergic rhinitis: influence of natural allergen exposure. J Allergy Clin Immunol 2000; 106:904-10.
33. Polosa R, Ciamarra I, Mangano G et al. Bronchial hyperresponsiveness and airway inflammation markers in nonasthmatics with allergic rhinitis. Eur Respir J 2000; 15:30-5.
34. Boulet LP, Morin D, Milot J, Turcotte H. Bronchial responsiveness increases after seasonal antigen exposure in non-asthmatic subjects with pollen-induced rhinitis. Ann Allergy 1989; 63:114-9.
35. Townley RG, Ryo UY, Kolotkin BM, Kang B. Bronchial sensitivity to methacholine in current and former asthmatic and allergic rhinitis patients and control subjects. J Allergy Clin Immunol 1975; 56:429-42.
36. Annesi I, Oryszczyn MP, Neukirch F, Orvoen-Frija E, Korobaeff M, Kauffmann F. Relationship of upper airways disorders to FEV1 and bronchial hyperresponsiveness in an epidemiological study. Eur Respir J 1992; 5:1104-10.
37. Laprise C, Laviolette M, Boutet M, Boulet LP. Asymptomatic airway hyperresponsiveness: relationships with airway inflammation and remodelling. Eur Respir J 1999; 14:63-73.
38. Amin K, Ludviksdottir D, Janson C et al. Inflammation and structural changes in the airways of patients with atopic and nonatopic asthma. BHR Group. Am J Respir Crit Care Med 2000; 162:2295-301.
39. Mitsunobu F, Mifune T, Hosaki Y et al. Different roles of histamine and leukotriene C4 in the airways between patients with atopic and nonatopic asthma. J Asthma 1998; 35:367-72.
40. Kotsimbos AT, Humbert M, Minshall E et al. Upregulation of alpha GM-CSF-receptor in nonatopic asthma but not in atopic asthma. J Allergy Clin Immunol 1997; 99:666-72.
41. Walker C, Bode E, Boer L, Hansel TT, Blaser K, Virchow JC Jr. Allergic and nonallergic asthmatics have distinct patterns of T-cell activation and cytokine production in peripheral blood and bronchoalveolar lavage. Am Rev Respir Dis 1992; 146:109-15.
42. Gelder CM, Thomas PS, Yates DH, Adcock IM, Morrison JF, Barnes PJ. Cytokine expression in normal, atopic, and asthmatic subjects using the combination of sputum induction and the polymerase chain reaction. Thorax 1995; 50:1033-7.
43. Iijima H, Duguet A, Eum SY, Hamid Q, Eidelman DH. Nitric oxide and protein nitration are eosinophil dependent in allergen-challenged mice. Am J Respir Crit Care Med 2001; 163:1233-40.
44. MacPherson JC, Comhair SA, Erzurum SC et al. Eosinophils are a major source of nitric oxide-derived oxidants in severe asthma: characterization of pathways available to eosinophils for generating reactive nitrogen species. J Immunol 2001; 166:5763-72.
45. Humbert M. Does 'intrinsic' asthma exist? Rev Mal Respir 2000; 17:245-54.
46. Humbert M, Durham SR, Ying S et al. IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against 'intrinsic' asthma being a distinct immunopathologic entity. Am J Respir Crit Care Med 1996; 154:1497-1504.
47. Humbert M, Menz G, Ying S et al. The immunopathology of extrinsic (atopic) and intrinsic (non-atopic) asthma: more similarities than differences. Immunol Today 1999; 20:528-33.
48. Thomassen MJ, Raychaudhuri B, Dweik RA et al. Nitric oxide regulation of asthmatic airway inflammation with segmental allergen challenge. J Allergy Clin Immunol 1999; 104:1174-82.
49. Menz G, Ying S, Durham SR et al. Molecular concepts of IgE-initiated inflammation in atopic and nonatopic asthma. Allergy 1998; 53:15-21.
50. Berlyne GS, Parameswaran K, Kamada D, Efthimiadis A, Hargreave FE. A comparison of exhaled nitric oxide and induced sputum as markers of airway inflammation. J Allergy Clin Immunol 2000; 106:638-44.
51. Gratziou C, Rovina N, Lignos M, Vogiatzis I, Roussos C. Exhaled nitric oxide in seasonal allergic rhinitis: influence of pollen season and therapy. Clin Exp Allergy 2001; 31:409-16.